Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver
Not Applicable
Completed
- Conditions
- Fatty Liver
- Interventions
- Dietary Supplement: omega 3 fatty acids
- Registration Number
- NCT04281121
- Lead Sponsor
- Ain Shams University
- Brief Summary
this is a prospective, interventional, open-label, randomized study on the efficacy of omega 3 fatty acids supplementation in Egyptian children with non-alcoholic fatty liver disease who had been selected from nutrition and outpatient clinic at Pediatric hospital, Ain Shams University
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Children between 5 - 16 years old with diffusely hyper echogenic liver at ultrasonography were included in the study.
Read More
Exclusion Criteria
- Patients with secondary causes of steatosis including total parenteral nutrition, drugs causing fatty liver disease for example steroids, hepatitis A, B, C, cytomegalovirus, Epstein-Barr virus infections, autoimmune liver disease, metabolic liver diseases, Wilson's disease, and alpha-1-antitrypsin deficiency.
- Patients currently taking fish oil supplements.
- Patients with systemic illness such as cardiac and kidney diseases.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description supplemented omega 3 fatty acids Life style modification, diet regimen and Omega-3 fatty acids supplementation non supplemented omega 3 fatty acids Life style modification and diet regimen
- Primary Outcome Measures
Name Time Method grade of fatty liver in children 3 month improvement
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Pediatrics hospital Ain shams University
🇪🇬Cairo, Egypt